日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EXTRA-PC: a phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer

EXTRA-PC:一项针对初治转移性激素敏感性前列腺癌患者的马索法尼汀(EPI-7386)联合恩扎卢胺的II期临床试验

Jang, Albert; Fowler, Peggy; Helminiak, Kathryn; Kumar, Hamsa L S; Pasucal, Jeffrey; Delong, Victoria; Zhong, Jeffrey Y; Jindal, Tanya; Grier, Abby L; Patel, Rishi R; Hislop, Mary; Cesano, Alessandra; Villaluna, Karen; Younginger, Brett; Wolff, Kayla; Richey, Kara; Bray, Julie; Garcia, Hannah; Adamowicz, Timothy; Reese, Amy; Nizam, Amanda; Gupta, Shilpa; Wee, Christopher E; Margevicius, Seunghee; Fu, Pingfu; Mendiratta, Prateek; Sheng, Iris Y; Brown, Jason R; Garcia, Jorge A; Barata, Pedro C